Who
Peter N. Reikes
Director
Company insider
Files Form 4 as: Director, Ionis Pharmaceuticals.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 23 Sep 2018
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,399 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,399 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,753 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,753 at $0.00 | filing |
| 15 Oct 2021filed 19 Oct 2021 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,777 at $0.00 | filing |
| 15 Oct 2021filed 19 Oct 2021 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,777 at $0.00 | filing |
| 15 Jul 2021filed 19 Jul 2021 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —5,333 at $0.00 | filing |
| 15 Jul 2021filed 19 Jul 2021 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 15 Jul 2021filed 19 Jul 2021 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,333 at $0.00 | filing |
| 15 Jul 2021filed 19 Jul 2021 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,333 at $0.00 | filing |
| 15 Oct 2020filed 19 Oct 2020 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 15 Oct 2020filed 19 Oct 2020 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 1 Jul 2020filed 6 Jul 2020 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 1 Jul 2020filed 6 Jul 2020 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,333 at $0.00 | filing |
| 1 Jul 2020filed 6 Jul 2020 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 1 Jul 2020filed 6 Jul 2020 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 15 Oct 2019filed 17 Oct 2019 | IONS Ionis Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
| 15 Oct 2019filed 17 Oct 2019 | IONS Ionis PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,778 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.